Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT03480971

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Led by Matrix Biomed, Inc. · Updated on 2024-11-20

120

Participants Needed

9

Research Sites

342 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A 10 week trial to assess the ability of Tempol to prevent and/or reduce toxicities associated with cisplatin and radiation treatment in head and neck cancer patients. Over the course of the 10 week trial, mucositis, nephrotoxicity, and ototoxicity will be monitored and assessed.

CONDITIONS

Official Title

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be 18 years of age or older with medically diagnosed squamous cell cancer of the head and neck
  • Scheduled to receive curative radiotherapy or proton therapy
  • Use effective birth control if female and of childbearing potential
  • Use adequate contraception if male and of childbearing potential; no sperm donation for 90 days after study
  • Receiving cisplatin chemotherapy
  • Provide informed consent and comply with study procedures
  • Have an ECOG performance status score of 2 or less
  • Life expectancy of at least 6 months
  • Adequate baseline organ function as defined by hematology, liver, renal, nutritional, and metabolic criteria
  • Absolute neutrophil count (ANC) of at least 1.5
  • Hemoglobin level of at least 10 g/dL
  • Platelet count of at least 100,000 per microliter of blood
  • Total bilirubin less than or equal to 2 times the upper limit of normal
  • Alanine amino transferase (ALT) and Aspartate aminotransferase (AST) less than or equal to 5 times upper limit of normal
  • Serum creatinine at or below upper limit of normal or creatinine clearance at least 60 mL/min if serum creatinine is elevated
  • Urine albumin less than 3.0 mg/dL
Not Eligible

You will not qualify if you...

  • Prior radiotherapy of the head and neck
  • Clinically significant infection requiring therapy within 14 days before starting treatment
  • Use of non-approved therapies for oral mucositis during or within 14 days before treatment
  • Use of mugard during or within 14 days before treatment
  • Use of prostaglandins, pentoxifylline, or leucovorin during or within 14 days before treatment
  • Use of certain mouthwashes (allopurinol, hydrogen peroxide, sucralfate, chlorhexidine) during or within 14 days before treatment
  • Recent serious non-malignant medical complications
  • Use of investigational drugs within 28 days before starting treatment
  • History of positive blood test for HIV
  • Significant active medical illness preventing study completion
  • Treatment plan including chemoradiation followed by further chemotherapy
  • Body weight less than 35 kg (77 lbs)
  • Pregnancy or breastfeeding
  • Known intolerance to platinum drugs
  • History of insulin-dependent diabetes mellitus
  • Hepatitis B or C infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

UCSD

La Jolla, California, United States, 92093

Actively Recruiting

2

Mercy Medical Center

Merced, California, United States, 95340

Actively Recruiting

3

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, California, United States, 94158

Active, Not Recruiting

4

Central Coast Medical Oncology

Santa Maria, California, United States, 93454

Actively Recruiting

5

Mission Hope Health Center

Santa Maria, California, United States, 93454

Actively Recruiting

6

Montefiore Medical Center-Einstein Campus

The Bronx, New York, United States, 10461

Actively Recruiting

7

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States, 27157

Actively Recruiting

8

Seattle Cancer Care Alliance

Seattle, Washington, United States, 98195

Actively Recruiting

9

University of Washington Medical Center

Seattle, Washington, United States, 98195

Actively Recruiting

Loading map...

Research Team

B

Benji Crane

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here